Pfizer Inc
- Entrepreneurs
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients…
Read More » - U.S. News
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
A sign advertises Covid vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, on Aug. 14, 2023. Brian Snyder |…
Read More » - U.S. News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. Dado Ruvic…
Read More » - News
Tim Cook, Elon Musk, Steve Schwarzman spotted at Xi Jinping dinner with U.S. CEOs
Apple CEO Tim Cook attends the “Senior Chinese Leader Event” held by the National Committee on US-China Relations and the…
Read More » - U.S. News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight…
Read More » - Entrepreneurs
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk,…
Read More » - U.S. News
Moderna posts quarterly loss as company takes $1.3 billion write-down on unused Covid shots
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Thursday posted a steep loss for the third quarter as the…
Read More » - Entrepreneurs
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter…
Read More » - News
CNBC Daily Open: Are things about to get more difficult?
Up from No. 13 in 2022, Minneapolis, Minnesota ranked as the No. 2 most neighborly city in America. S. Greg…
Read More » - News
Jamie Dimon’s stock-moving trades show why investors should track CEOs’ buying and selling
For the first time in nearly two decades running JPMorgan Chase, CEO Jamie Dimon will voluntarily sell stock in the…
Read More »
